These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 37198702)
1. Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects. El-Moamly AA; El-Sweify MA Trop Med Health; 2023 May; 51(1):29. PubMed ID: 37198702 [TBL] [Abstract][Full Text] [Related]
2. The march toward malaria vaccines. Hoffman SL; Vekemans J; Richie TL; Duffy PE Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [TBL] [Abstract][Full Text] [Related]
3. Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough? Arora N; C Anbalagan L; Pannu AK Risk Manag Healthc Policy; 2021; 14():1033-1039. PubMed ID: 33737844 [TBL] [Abstract][Full Text] [Related]
4. [The world's first malaria vaccine: Hope and challenge]. Zhang YL; Pan WQ Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Jan; 33(6):560-562. PubMed ID: 35128884 [TBL] [Abstract][Full Text] [Related]
5. The March Toward Malaria Vaccines. Hoffman SL; Vekemans J; Richie TL; Duffy PE Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432 [TBL] [Abstract][Full Text] [Related]
6. "I would have to sell things in order to get the money": A qualitative exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta region, Ghana. Darkwa S; de Wildt G; Dalaba M; Vidzro E; Ansah EK PLoS One; 2022; 17(6):e0268009. PubMed ID: 35675273 [TBL] [Abstract][Full Text] [Related]
7. A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 Ndungu FM; Mwacharo J; Wambua J; Njuguna P; Marsh K; Drakeley C; Bejon P Wellcome Open Res; 2019; 4():42. PubMed ID: 31168483 [No Abstract] [Full Text] [Related]
8. Malaria Vaccines: Moving Forward After Encouraging First Steps. Tran TM; Portugal S; Draper SJ; Crompton PD Curr Trop Med Rep; 2015 Mar; 2(1):1-3. PubMed ID: 25995985 [TBL] [Abstract][Full Text] [Related]
9. RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of Plasmodium falciparum. von Seidlein L; Hanboonkunupakarn B; Jittmala P; Pukrittayakamee S Emerg Top Life Sci; 2017 Dec; 1(6):533-537. PubMed ID: 33525840 [TBL] [Abstract][Full Text] [Related]
10. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial. Valéa I; Adjei S; Usuf E; Traore O; Ansong D; Tinto H; Owusu Boateng H; Leach A; Mwinessobaonfou Some A; Buabeng P; Vekemans J; Nana LA; Kotey A; Vandoolaeghe P; Ouedraogo F; Sambian D; Lievens M; Tahita MC; Rettig T; Jongert E; Lompo P; Idriss A; Borys D; Ouedraogo S; Prempeh F; Habib MA; Schuerman L; Sorgho H; Agbenyega T Hum Vaccin Immunother; 2018 Jun; 14(6):1489-1500. PubMed ID: 29630438 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in infants: a systematic review and meta-analysis. Mahmoudi S; Keshavarz H Hum Vaccin Immunother; 2017 Jan; ():0. PubMed ID: 28059665 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519 [TBL] [Abstract][Full Text] [Related]
13. Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice. Brod F; Miura K; Taylor I; Li Y; Marini A; Salman AM; Spencer AJ; Long CA; Biswas S Front Immunol; 2018; 9():2780. PubMed ID: 30564231 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan. Mahmoudi S; Keshavarz H Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979 [TBL] [Abstract][Full Text] [Related]
15. Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation. Tachibana M; Takashima E; Morita M; Sattabongkot J; Ishino T; Culleton R; Torii M; Tsuboi T Parasitol Int; 2022 Apr; 87():102525. PubMed ID: 34896614 [TBL] [Abstract][Full Text] [Related]